Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Educational level, management and outcomes in small-cell lung cancer (SCLC): A population-based cohort study.

Tendler S, Holmqvist M, Wagenius G, Lewensohn R, Lambe M, De Petris L.

Lung Cancer. 2020 Jan;139:111-117. doi: 10.1016/j.lungcan.2019.11.008. Epub 2019 Nov 14.

PMID:
31760352
2.

Addressing the hardest endpoint.

Ljung L, Holmqvist M.

Rheumatology (Oxford). 2019 Oct 23. pii: kez514. doi: 10.1093/rheumatology/kez514. [Epub ahead of print] No abstract available.

PMID:
31642913
3.

Older persons' experiences regarding evaluation of their medication treatment-An interview study in Sweden.

Holmqvist M, Thor J, Ros A, Johansson L.

Health Expect. 2019 Dec;22(6):1294-1303. doi: 10.1111/hex.12967. Epub 2019 Sep 26.

4.

Reproductive Pattern in Women with Idiopathic Inflammatory Myopathy - a Population-based Study.

Che WI, Hellgren K, Lundberg IE, Holmqvist M.

J Rheumatol. 2019 Aug 15. pii: jrheum.190474. doi: 10.3899/jrheum.190474. [Epub ahead of print]

PMID:
31416924
5.

Anti-transcriptional intermediary factor 1 gamma antibodies in cancer-associated myositis: a longitudinal study.

Dani L, Holmqvist M, Martínez MA, Trallero-Araguas E, Dastmalchi M, Svensson J, Labrador-Horrillo M, Selva-O'Callaghan A, Lundberg IE.

Clin Exp Rheumatol. 2019 Jul 30. [Epub ahead of print]

PMID:
31365334
6.

Efficacy and Safety of Sesame Oral Immunotherapy-A Real-World, Single-Center Study.

Nachshon L, Goldberg MR, Levy MB, Appel MY, Epstein-Rigbi N, Lidholm J, Holmqvist M, Katz Y, Elizur A.

J Allergy Clin Immunol Pract. 2019 Nov - Dec;7(8):2775-2781.e2. doi: 10.1016/j.jaip.2019.05.031. Epub 2019 May 29.

PMID:
31150789
7.

Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjögren's syndrome.

Mofors J, Holmqvist M, Westermark L, Björk A, Kvarnström M, Forsblad-d'Elia H, Magnusson Bucher S, Eriksson P, Theander E, Mandl T, Wahren-Herlenius M, Nordmark G.

J Intern Med. 2019 Oct;286(4):458-468. doi: 10.1111/joim.12941. Epub 2019 Jun 17.

8.

Methotrexate in Our Hearts.

Ljung L, Holmqvist M.

J Rheumatol. 2019 May;46(5):447-449. doi: 10.3899/jrheum.181269. No abstract available.

PMID:
31043496
9.

Response to: 'Inflammatory and non-inflammatory triggers of acute coronary syndromes' by Eyuboglu.

Westerlind H, Holmqvist M, Ljung L, Frisell T, Askling J.

Ann Rheum Dis. 2019 Mar 28. pii: annrheumdis-2019-215293. doi: 10.1136/annrheumdis-2019-215293. [Epub ahead of print] No abstract available.

PMID:
30923234
10.

Acute Coronary Syndrome in Idiopathic Inflammatory Myopathies: A Population-based Study.

Leclair V, Svensson J, Lundberg IE, Holmqvist M.

J Rheumatol. 2019 Nov;46(11):1509-1514. doi: 10.3899/jrheum.181248. Epub 2019 Mar 15.

PMID:
30877220
11.

Siblings of patients with rheumatoid arthritis are at increased risk of acute coronary syndrome.

Westerlind H, Holmqvist M, Ljung L, Frisell T, Askling J.

Ann Rheum Dis. 2019 May;78(5):683-687. doi: 10.1136/annrheumdis-2018-214828. Epub 2019 Feb 20.

PMID:
30787006
12.

Reply.

Holmqvist M.

Arthritis Care Res (Hoboken). 2019 Oct;71(10):1396-1397. doi: 10.1002/acr.23850. Epub 2019 Aug 23. No abstract available.

PMID:
30768774
13.

Comparison of autoantibody specificities tested by a line blot assay and immunoprecipitation-based algorithm in patients with idiopathic inflammatory myopathies.

Espinosa-Ortega F, Holmqvist M, Alexanderson H, Storfors H, Mimori T, Lundberg IE, Rönnelid J.

Ann Rheum Dis. 2019 Jun;78(6):858-860. doi: 10.1136/annrheumdis-2018-214690. Epub 2019 Feb 13. No abstract available.

PMID:
30760469
14.

Physical activity promotion in Manitoba: Strengths, needs, and moving forward.

Kosowan L, Wener P, Holmqvist M, Gonzalez M, Halas G, Rothney J, Katz A.

SAGE Open Med. 2019 Jan 28;7:2050312118822910. doi: 10.1177/2050312118822910. eCollection 2019.

15.

A Scoping Review of Foci, Trends, and Gaps in Reviews of Tobacco Control Research.

Halas G, Schultz AS, Rothney J, Wener P, Holmqvist M, Cohen B, Kosowan L, Enns JE, Katz A.

Nicotine Tob Res. 2019 Feb 2. doi: 10.1093/ntr/nty269. [Epub ahead of print]

PMID:
30715468
16.

Efficacy and safety of rituximab in anti-synthetase antibody positive and negative subjects with idiopathic inflammatory myopathy: a registry-based study.

Leclair V, Galindo-Feria AS, Dastmalchi M, Holmqvist M, Lundberg IE.

Rheumatology (Oxford). 2019 Jul 1;58(7):1214-1220. doi: 10.1093/rheumatology/key450.

PMID:
30690633
17.

The Risk of Ischemic and Hemorrhagic Stroke in Patients With Idiopathic Inflammatory Myopathies: A Swedish Population-Based Cohort Study.

Moshtaghi-Svensson J, Lundberg IE, Von Euler M, Arkema EV, Holmqvist M.

Arthritis Care Res (Hoboken). 2019 Jul;71(7):970-976. doi: 10.1002/acr.23702.

PMID:
29999244
18.

Medication Management in Municipality-Based Healthcare: A Time and Motion Study of Nurses.

Holmqvist M, Ekstedt M, Walter SR, Lehnbom EC.

Home Healthc Now. 2018 Jul/Aug;36(4):238-246. doi: 10.1097/NHH.0000000000000671.

PMID:
29979305
19.

Venous Thromboembolic Events in Idiopathic Inflammatory Myopathy: Occurrence and Relation to Disease Onset.

Antovic A, Notarnicola A, Svensson J, Lundberg IE, Holmqvist M.

Arthritis Care Res (Hoboken). 2018 Dec;70(12):1849-1855. doi: 10.1002/acr.23560.

20.

Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme.

Yamanaka H, Askling J, Berglind N, Franzen S, Frisell T, Garwood C, Greenberg JD, Ho M, Holmqvist M, Novelli Horne L, Inoue E, Michaud K, Pappas DA, Reed G, Symmons D, Tanaka E, Tran TN, Verstappen SMM, Wesby-van Swaay E, Nyberg F.

RMD Open. 2017 Oct 10;3(2):e000498. doi: 10.1136/rmdopen-2017-000498. eCollection 2017.

21.

Mortality following new-onset Rheumatoid Arthritis: has modern Rheumatology had an impact?

Holmqvist M, Ljung L, Askling J.

Ann Rheum Dis. 2018 Jan;77(1):85-91. doi: 10.1136/annrheumdis-2017-212131. Epub 2017 Sep 26.

PMID:
28970218
22.

Infections and respiratory tract disease as risk factors for idiopathic inflammatory myopathies: a population-based case-control study.

Svensson J, Holmqvist M, Lundberg IE, Arkema EV.

Ann Rheum Dis. 2017 Nov;76(11):1803-1808. doi: 10.1136/annrheumdis-2017-211174. Epub 2017 Aug 30.

PMID:
28855175
23.

Long-term outcomes and secondary prevention after acute coronary events in patients with rheumatoid arthritis.

Mantel Ä, Holmqvist M, Jernberg T, Wållberg-Jonsson S, Askling J.

Ann Rheum Dis. 2017 Dec;76(12):2017-2024. doi: 10.1136/annrheumdis-2017-211608. Epub 2017 Aug 20.

PMID:
28823986
24.

Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study.

Dobloug GC, Svensson J, Lundberg IE, Holmqvist M.

Ann Rheum Dis. 2018 Jan;77(1):40-47. doi: 10.1136/annrheumdis-2017-211402. Epub 2017 Aug 16. Erratum in: Ann Rheum Dis. 2018 May;77(5):786.

PMID:
28814428
25.

Acute coronary syndrome in new-onset rheumatoid arthritis: a population-based nationwide cohort study of time trends in risks and excess risks.

Holmqvist M, Ljung L, Askling J.

Ann Rheum Dis. 2017 Oct;76(10):1642-1647. doi: 10.1136/annrheumdis-2016-211066. Epub 2017 Jul 14.

PMID:
28710095
26.

Editorial: Is Rheumatoid Arthritis a Mortal Disease?

Askling J, Holmqvist M, Ljung L.

Arthritis Rheumatol. 2017 Aug;69(8):1509-1511. doi: 10.1002/art.40145. Epub 2017 Jul 13. No abstract available.

27.

Association Between Rheumatoid Arthritis and Risk of Ischemic and Nonischemic Heart Failure.

Mantel Ä, Holmqvist M, Andersson DC, Lund LH, Askling J.

J Am Coll Cardiol. 2017 Mar 14;69(10):1275-1285. doi: 10.1016/j.jacc.2016.12.033.

28.

Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study.

Svensson J, Arkema EV, Lundberg IE, Holmqvist M.

Rheumatology (Oxford). 2017 May 1;56(5):802-810. doi: 10.1093/rheumatology/kew503.

PMID:
28160487
29.

Use of biologic agents in idiopathic inflammatory myopathies in Sweden: a descriptive study of real life treatment.

Svensson J, Holmqvist M, Tjärnlund A, Dastmalchi M, Hanna B, Magnusson Bucher S, Lundberg IE.

Clin Exp Rheumatol. 2017 May-Jun;35(3):512-515. Epub 2016 Dec 9.

PMID:
27974098
30.

Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis.

Ozen G, Pedro S, Holmqvist ME, Avery M, Wolfe F, Michaud K.

Ann Rheum Dis. 2017 May;76(5):848-854. doi: 10.1136/annrheumdis-2016-209954. Epub 2016 Nov 11.

PMID:
27836820
31.

A validation of DCIS registration in a population-based breast cancer quality register and a study of treatment and prognosis for DCIS during 20 years.

Wadsten C, Heyman H, Holmqvist M, Ahlgren J, Lambe M, Sund M, Wärnberg F.

Acta Oncol. 2016 Nov;55(11):1338-1343. Epub 2016 Aug 22.

PMID:
27548561
32.

Mapping interventions that promote mental health in the general population: A scoping review of reviews.

Enns J, Holmqvist M, Wener P, Halas G, Rothney J, Schultz A, Goertzen L, Katz A.

Prev Med. 2016 Jun;87:70-80. doi: 10.1016/j.ypmed.2016.02.022. Epub 2016 Feb 17. Review.

PMID:
26896634
33.

Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease.

Michaud K, Berglind N, Franzén S, Frisell T, Garwood C, Greenberg JD, Ho M, Holmqvist M, Horne L, Inoue E, Nyberg F, Pappas DA, Reed G, Symmons D, Tanaka E, Tran TN, Verstappen SM, Wesby-van Swaay E, Yamanaka H, Askling J.

Ann Rheum Dis. 2016 Oct;75(10):1797-805. doi: 10.1136/annrheumdis-2015-208698. Epub 2016 Feb 8.

PMID:
26857699
34.

Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies.

Holmqvist M, Simard JF, Asplund K, Arkema EV.

RMD Open. 2015 Dec 16;1(1):e000168. doi: 10.1136/rmdopen-2015-000168. eCollection 2015. Review.

35.

How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries.

Askling J, Berglind N, Franzen S, Frisell T, Garwood C, Greenberg JD, Ho M, Holmqvist M, Horne L, Inoue E, Michaud K, Nyberg F, Pappas DA, Reed G, Tanaka E, Tran TN, Verstappen SM, Yamanaka H, Wesby-van Swaay E, Symmons D.

Ann Rheum Dis. 2016 Oct;75(10):1789-96. doi: 10.1136/annrheumdis-2015-208105. Epub 2015 Nov 30.

PMID:
26621482
36.

Rheumatoid arthritis is associated with a more severe presentation of acute coronary syndrome and worse short-term outcome.

Mantel Ä, Holmqvist M, Jernberg T, Wållberg-Jonsson S, Askling J.

Eur Heart J. 2015 Dec 21;36(48):3413-22. doi: 10.1093/eurheartj/ehv461. Epub 2015 Sep 23.

PMID:
26400826
37.

Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach.

Nyberg F, Askling J, Berglind N, Franzén S, Ho M, Holmqvist M, Horne L, Lampl K, Michaud K, Pappas DA, Reed G, Symmons D, Tanaka E, Tran TN, Verstappen SM, Wesby-van Swaay E, Yamanaka H, Greenberg JD.

Pharmacoepidemiol Drug Saf. 2015 Nov;24(11):1121-32. doi: 10.1002/pds.3854. Epub 2015 Aug 25.

PMID:
26303866
38.

Methodological Challenges When Comparing Demographic and Clinical Characteristics of International Observational Registries.

Verstappen SM, Askling J, Berglind N, Franzen S, Frisell T, Garwood C, Greenberg JD, Holmqvist M, Horne L, Lampl K, Michaud K, Nyberg F, Pappas DA, Reed G, Symmons DP, Tanaka E, Tran TN, Yamanaka H, Ho M.

Arthritis Care Res (Hoboken). 2015 Dec;67(12):1637-45. doi: 10.1002/acr.22661.

39.

Risk factors for the rapid increase in risk of acute coronary events in patients with new-onset rheumatoid arthritis: a nested case-control study.

Mantel Ä, Holmqvist M, Nyberg F, Tornling G, Frisell T, Alfredsson L, Askling J.

Arthritis Rheumatol. 2015 Nov;67(11):2845-54. doi: 10.1002/art.39267.

40.

Blessed art thou among women: male nursing students and gender inequalities in Chile.

Ayala RA, Holmqvist MT, Messing HB, Browne RF.

Nurse Educ Today. 2014 Dec;34(12):1480-4. doi: 10.1016/j.nedt.2014.04.022. Epub 2014 May 9.

PMID:
24837518
41.

A1M/α1-microglobulin protects from heme-induced placental and renal damage in a pregnant sheep model of preeclampsia.

Wester-Rosenlöf L, Casslén V, Axelsson J, Edström-Hägerwall A, Gram M, Holmqvist M, Johansson ME, Larsson I, Ley D, Marsal K, Mörgelin M, Rippe B, Rutardottir S, Shohani B, Akerström B, Hansson SR.

PLoS One. 2014 Jan 28;9(1):e86353. doi: 10.1371/journal.pone.0086353. eCollection 2014.

42.

Web- vs. telehealth-based delivery of cognitive behavioral therapy for insomnia: a randomized controlled trial.

Holmqvist M, Vincent N, Walsh K.

Sleep Med. 2014 Feb;15(2):187-95. doi: 10.1016/j.sleep.2013.10.013. Epub 2013 Dec 31.

PMID:
24461370
43.

Time trends in T3 to T4 laryngeal cancer: a population-based long-term analysis.

Reizenstein JA, Holmberg L, Bergqvist M, Linder A, Ekman S, Lödén B, Holmqvist M, Hellström K, von Beckerath M, Blomquist E, Bergström SN.

Head Neck. 2014 Dec;36(12):1727-31. doi: 10.1002/hed.23524. Epub 2014 Jan 29.

PMID:
24166872
44.

Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor/anti-citrullinated protein antibody status, number and type of affected relatives, sex, and age.

Frisell T, Holmqvist M, Källberg H, Klareskog L, Alfredsson L, Askling J.

Arthritis Rheum. 2013 Nov;65(11):2773-82. doi: 10.1002/art.38097.

45.

Parity and the risk of developing rheumatoid arthritis: results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis study.

Orellana C, Wedrén S, Källberg H, Holmqvist M, Karlson EW, Alfredsson L, Bengtsson C; EIRA Study Group.

Ann Rheum Dis. 2014 Apr;73(4):752-5. doi: 10.1136/annrheumdis-2013-203567. Epub 2013 Jul 25.

46.

Regional differences regarding risk of developing rheumatoid arthritis in Stockholm County, Sweden: results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA) study.

Källberg H, Vieira V, Holmqvist M, Hart JE, Costenbader KH, Bengtsson C, Klareskog L, Karlson EW, Alfredsson L.

Scand J Rheumatol. 2013;42(5):337-43. doi: 10.3109/03009742.2013.769062. Epub 2013 Apr 23.

47.

Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden.

Raaschou P, Simard JF, Holmqvist M, Askling J; ARTIS Study Group.

BMJ. 2013 Apr 8;346:f1939. doi: 10.1136/bmj.f1939.

48.

The characterisation and risk factors of ischaemic heart disease in patients with coeliac disease.

Emilsson L, Carlsson R, Holmqvist M, James S, Ludvigsson JF.

Aliment Pharmacol Ther. 2013 May;37(9):905-14. doi: 10.1111/apt.12271. Epub 2013 Mar 4.

49.

[Observational cohort studies. Overview and some examples from the field of drug safety].

Holmqvist M, Raaschou P, Neovius M, Askling J.

Lakartidningen. 2013 Jan 16-22;110(3):82-4. Swedish. No abstract available.

PMID:
23424984
50.

Attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) in adult psychiatry. A 20-year register study.

Nylander L, Holmqvist M, Gustafson L, Gillberg C.

Nord J Psychiatry. 2013 Oct;67(5):344-50. doi: 10.3109/08039488.2012.748824. Epub 2012 Dec 12.

PMID:
23234539

Supplemental Content

Loading ...
Support Center